International Conference on Hematology and Clinical Trials
(ICHCT-26)

27th September 2026 || Chandigarh - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Hematology and Clinical Trials (ICHCT), scheduled to be held on 27th September 2026 in Chandigarh, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Hematology.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in Hematology Clinical Trials
    This track will explore recent innovations in the design and execution of clinical trials within hematology. Emphasis will be placed on methodologies that enhance patient recruitment and retention, as well as strategies to improve trial outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Molecular Diagnostics in Hematology
    This session will focus on the latest advancements in molecular diagnostics that are transforming the landscape of hematological disorders. Participants will discuss the implications of these technologies for early detection and personalized treatment approaches. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 03 – Laboratory Innovations in Hematology
    This track will highlight cutting-edge laboratory techniques and technologies that are improving diagnostic accuracy and efficiency in hematology. Discussions will include automation, high-throughput screening, and novel assay development. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Therapeutic Strategies in Hematological Disorders
    This session will examine emerging therapeutic strategies for the treatment of various hematological conditions. Topics will include novel drug development, combination therapies, and the role of immunotherapy. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 05 – Translational Research in Hematology
    This track will delve into the translation of laboratory findings into clinical applications in hematology. Researchers will present their work on bridging the gap between basic science and patient care. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 06 – Understanding Disease Mechanisms in Hematology
    This session will focus on the underlying mechanisms of hematological diseases, including genetic, epigenetic, and environmental factors. Insights gained from this research are crucial for developing targeted therapies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 07 – Clinical Outcomes in Hematology Trials
    This track will evaluate the clinical outcomes of recent hematology trials, providing insights into efficacy and safety profiles of new treatments. Discussions will also cover the impact of these outcomes on clinical practice. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 08 – Biomarker Discovery in Hematology
    This session will explore the identification and validation of biomarkers that can predict treatment response and disease progression in hematological disorders. The role of biomarkers in personalized medicine will be a key focus. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 09 – Patient-Centered Care in Hematology
    This track will emphasize the importance of patient-centered approaches in hematology care and clinical trials. Discussions will include strategies for enhancing patient engagement and improving quality of life. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 10 – Ethical Considerations in Hematology Research
    This session will address the ethical challenges and considerations specific to conducting research in hematology. Topics will include informed consent, patient safety, and the ethical implications of novel therapies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 16 – Peace, Justice and Strong Institutions
  • Track 11 – Global Perspectives on Hematology Clinical Trials
    This track will provide a platform for discussing the global landscape of hematology clinical trials, including challenges and opportunities in diverse populations. Participants will share insights on international collaboration and regulatory considerations. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 17 – Partnerships for the Goals
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure
  • SDG 10 SDG 10
    Reduced Inequalities
  • SDG 16 SDG 16
    Peace, Justice and Strong Institutions
  • SDG 17 SDG 17
    Partnerships for the Goals

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228